Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes
empagliflozin
1245.23
NCT01159600
Diabetes Mellitus, Type 2
Phase 3
 
December 2014

Powered by ideaPoint, Inc.